DLAT Antikörper (AA 374-631)
Kurzübersicht für DLAT Antikörper (AA 374-631) (ABIN7569009)
Target
Alle DLAT Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 374-631
-
Verwendungszweck
- Anti-Human DLAT Polyclonal Antibody
-
Aufreinigung
- Antigen affinity purification.
-
Immunogen
- E. coli - derived recombinant Human DLAT (Gln374-Trp631).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 0.01M PBS, pH 7.4, 50 % glycerol, 0.05 % Proclin 300.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C,-80 °C
-
Informationen zur Lagerung
- Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 4°C for frequent use.Store at -20 to -80 °C for twelve months from the date of receipt.
-
-
- DLAT (Dihydrolipoyl Transacetylase (DLAT))
-
Andere Bezeichnung
- DLAT
-
Hintergrund
- DLTA, M2 antigen complex 70 kDa subunit, 70 kDa mitochondrial autoantigen of primary biliary cirrhosis, Pyruvate dehydrogenase complex component E2, PDC-E2, DLAT, PBC, Dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex, Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial, PDCE2
-
UniProt
- P10515
Target
-